title: Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
abstract: To contribute to the development of a rubella vaccination strategy, we conducted a study to determine age-specific susceptibility among women aged 15-39 years by testing for rubella-specific IgG antibodies. Of 964 women, 13% were found to be susceptible to rubella. Significantly higher susceptibility among women >25 years old was observed. Susceptibility data are important but are not sufficient to develop a vaccination strategy. After considering all available information, we suggested vaccination of women aged <35 years and selective vaccination of older women who were planning pregnancy.
authors.affiliation: Polio Eradication Branch, Global Immunization Division, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. nailemlk@yahoo.com
authors.forename: Naile
authors.initials: N
authors.lastname: Malakmadze
authors.forename: Laura A
authors.initials: LA
authors.lastname: Zimmerman
authors.forename: Amra
authors.initials: A
authors.lastname: Uzicanin
authors.forename: Luidmila
authors.initials: L
authors.lastname: Shteinke
authors.forename: Victor M
authors.initials: VM
authors.lastname: Caceres
authors.forename: Kaliya
authors.initials: K
authors.lastname: Kasymbekova
authors.forename: Irina
authors.initials: I
authors.lastname: Sozina
authors.forename: John W
authors.initials: JW
authors.lastname: Glasser
authors.forename: Mira
authors.initials: M
authors.lastname: Joldubaeva
authors.forename: Chinara
authors.initials: C
authors.lastname: Aidyralieva
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Icenogle
authors.forename: Peter M
authors.initials: PM
authors.lastname: Strebel
authors.forename: Susan E
authors.initials: SE
authors.lastname: Reef
mesh_terms: D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D005260:Female; D006801:Humans; D007110:Immunity, Active; D007707:Kyrgyzstan; D012409:Rubella / Q000276:immunology* / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000008:administration & dosage*; D012412:Rubella virus / Q000276:immunology; D014611:Vaccination / Q000592:standards
chemical_list: D000914:Antibodies, Viral; D012411:Rubella Vaccine